Lobular Breast Cancer: Different Disease, Different Algorithms?

[1]  M. Morrow,et al.  Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy , 2017, Annals of Surgical Oncology.

[2]  Alphonse G. Taghian,et al.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. , 2017, Practical radiation oncology.

[3]  P. Campbell,et al.  Genomic Characterization of Primary Invasive Lobular Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Xinglei Shen,et al.  Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study. , 2016, Clinical breast cancer.

[5]  S. Siesling,et al.  Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer. , 2016, Clinical breast cancer.

[6]  D. Steinemann,et al.  Lobular breast cancer: Clinical, molecular and morphological characteristics. , 2016, Pathology, research and practice.

[7]  G. Plitas,et al.  How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study , 2016, Annals of Surgical Oncology.

[8]  O. Metzger-Filho,et al.  Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications , 2016, Therapeutic advances in medical oncology.

[9]  C. Perou,et al.  Collective Wisdom: Lobular Carcinoma of the Breast. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[10]  Steven J. M. Jones,et al.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.

[11]  A. Giobbie-Hurder,et al.  Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Tjan-Heijnen,et al.  Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer , 2015, Annals of Surgical Oncology.

[13]  E. Winer,et al.  Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast , 2015, Annals of Surgical Oncology.

[14]  J. Brock,et al.  Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin , 2015, Breast Cancer Research and Treatment.

[15]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[16]  Y. Lim,et al.  The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  C. Kleer,et al.  Re-Excision Rates of Invasive Ductal Carcinoma with Lobular Features Compared with Invasive Ductal Carcinomas and Invasive Lobular Carcinomas of the Breast , 2014, Annals of Surgical Oncology.

[18]  D. Dabbs,et al.  Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. , 2014, Cancer research.

[19]  Seema A Khan,et al.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Seema A. Khan,et al.  Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer , 2014, Annals of Surgical Oncology.

[21]  P. Fasching,et al.  Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma , 2014, Breast Cancer Research and Treatment.

[22]  Tari A King,et al.  Lobular neoplasia. , 2014, Surgical oncology clinics of North America.

[23]  S. Barni,et al.  Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer , 2013, Breast Cancer Research and Treatment.

[24]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  C. Sotiriou,et al.  Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  N. Biglia,et al.  Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[28]  R. Turner,et al.  Preoperative Magnetic Resonance Imaging in Breast Cancer: Meta-Analysis of Surgical Outcomes , 2013, Annals of surgery.

[29]  G. Hortobagyi,et al.  Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas , 2013, British Journal of Cancer.

[30]  H. Putter,et al.  Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. , 2013, European journal of cancer.

[31]  S. Siesling,et al.  Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  D. Berry,et al.  Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer , 2012, Breast Cancer Research and Treatment.

[33]  H. Kuerer,et al.  Invasive lobular carcinoma predicts micrometastasis in breast cancer. , 2012, The Journal of surgical research.

[34]  M. Gnant,et al.  Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients , 2012, Annals of Surgical Oncology.

[35]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[36]  T. Major,et al.  Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results. , 2011, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[37]  Early Breast Cancer Trialists' Collaborative Group.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[38]  R Peto,et al.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[39]  J. Dixon,et al.  Invasive lobular carcinoma: response to neoadjuvant letrozole therapy , 2011, Breast Cancer Research and Treatment.

[40]  J. Olson,et al.  Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  S. Huffel,et al.  Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients , 2011, Breast Cancer Research and Treatment.

[42]  A. Luini,et al.  Influence of Margin Status on Outcomes in Lobular Carcinoma: Experience of the European Institute of Oncology , 2011, Annals of surgery.

[43]  B. Rosner,et al.  Risk factors for ductal and lobular breast cancer: results from the nurses' health study , 2010, Breast Cancer Research.

[44]  Kelly K. Hunt,et al.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.

[45]  Karla Kerlikowske,et al.  Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[46]  Nabil Wasif,et al.  Invasive Lobular vs. Ductal Breast Cancer: A Stage-Matched Comparison of Outcomes , 2010, Annals of Surgical Oncology.

[47]  I. Ellis,et al.  Lobular breast carcinoma and its variants. , 2010, Seminars in diagnostic pathology.

[48]  J. Costantino,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Babiera,et al.  Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation , 2009, Annals of Surgical Oncology.

[50]  Melissa P. Murray,et al.  Is pleomorphic lobular carcinoma really a distinct clinical entity? , 2008, Journal of surgical oncology.

[51]  M. Ross,et al.  Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients , 2008, Annals of Surgical Oncology.

[52]  B. Fornage,et al.  Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. , 2007, American journal of surgery.

[53]  M. Morrow.  Selecting Patients for Breast-Conserving Therapy: The Importance of Lobular HistologyMorrow M, Keeney K, Scholtens D, et al (Fox Chase Cancer Ctr, Philadelphia; Northwestern Univ, Chicago) Cancer 106:2563–2568, 2006§ , 2007 .

[54]  Michael Gnant,et al.  Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF , 2007, Breast Cancer Research and Treatment.

[55]  P. Chérel,et al.  Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  A. Buzdar,et al.  Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer , 2006, Cancer.

[57]  M. Ross,et al.  Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. , 2005, American journal of surgery.

[58]  S. Harms,et al.  Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. , 2005, American journal of surgery.

[59]  J. Daling,et al.  Clinical characteristics of different histologic types of breast cancer , 2005, British Journal of Cancer.

[60]  M. Dowsett,et al.  Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  G. Hortobagyi,et al.  Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  H. Carmalt,et al.  Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. , 2004, Breast.

[63]  P. Bult,et al.  The Role of MRI in Invasive Lobular Carcinoma , 2004, Breast Cancer Research and Treatment.

[64]  R. Rouzier,et al.  The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. , 2004, European journal of cancer.

[65]  P. Blondeel,et al.  Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[66]  P. Drew,et al.  Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  K. Horgan,et al.  Role of magnetic resonance imaging in the diagnosis and single‐stage surgical resection of invasive lobular carcinoma of the breast , 2002, The British journal of surgery.

[68]  M. Wadley,et al.  The diagnosis of invasive lobular breast carcinoma. Does MRI have a role? , 2001, Breast.

[69]  J. Imbrie,et al.  Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. , 2000, Annals of surgery.

[70]  R. Schmidt,et al.  Patient selection for breast conservation therapy with magnification mammography. , 1995, Surgery.